Aura Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.7M | $160.0M | $149.1M |
| FY2022 | $28.4M | $223.9M | $121.6M |
| FY2023 | $29.2M | $255.1M | $41.1M |
| FY2024 | $30.5M | $182.5M | $31.7M |
| FY2025 | $32.5M | $169.4M | $59.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.7M | $160.0M | $149.1M |
| FY2022 | $28.4M | $223.9M | $121.6M |
| FY2023 | $29.2M | $255.1M | $41.1M |
| FY2024 | $30.5M | $182.5M | $31.7M |
| FY2025 | $32.5M | $169.4M | $59.5M |